Archive for the ‘Treatment’ Category

How a False Hydroxychloroquine Narrative Was Created

https://articles.mercola.com/sites/articles/archive/2020/07/15/hydroxychloroquine-for-coronavirus.aspx?  News Video Here (Interview with Dr. Zelenko who explains the HCQ protocol.  PLEASE WATCH – very informative.)

STORY AT-A-GLANCE

  • The controversy over hydroxychloroquine is perhaps one of the most perplexing and frustrating. Doctors and health experts around the world have spoken out both for and against the use of the drug, some reporting spectacular benefits while others warn of mortal dangers
  • In an international poll of 6,227 doctors in 30 countries, 37% rated the antimalaria drug hydroxychloroquine as “the most effective therapy” for COVID-19. In Spain, where the drug was used by 72% of doctors, it was rated “the most effective therapy” by 75% of them
  • French microbiologist and infectious disease expert Didier Raoult reported a combination of hydroxychloroquine and azithromycin administered immediately upon diagnosis led to recovery and “virological cure” — nondetection of SARS-CoV-2 in nasal swabs — in 91.7% of patients
  • Dr. Vladimir Zelenko has found treating COVID-19 patients who had confirmed positive test results “as early as possible after symptom onset” with zinc, low dose hydroxychloroquine and azithromycin lowered mortality fivefold
  • Zinc appears to be key. If given early, zinc along with a zinc ionophore such as hydroxychloroquine or quercetin should, at least theoretically, help lower the viral load and prevent the immune system from becoming overloaded

There’s no shortage of controversies surrounding the COVID-19 pandemic, but the controversy over hydroxychloroquine is perhaps one of the most perplexing and frustrating. Doctors and health experts around the world have spoken out both for and against the use of the drug, some reporting spectacular benefits1 while others warn of mortal dangers.2

Game-Changer or Deadly Treatment?

In one international poll3 of 6,227 doctors in 30 countries, 37% rated the antimalaria drug hydroxychloroquine as “the most effective therapy” for COVID-19. The poll was done by Sermo, the world’s largest health care data collection company and social platform for physicians.

In Spain, where the drug was used by 72% of doctors, it was rated “the most effective therapy” by 75% of them. The typical dose used by a majority of doctors was 400 milligrams per day.

French science-prize winning microbiologist and infectious disease expert Didier Raoult, founder and director of the research hospital Institut Hospitalo-Universitaire Méditerranée Infection,4reported5,6 that a combination of hydroxychloroquine and azithromycin, administered immediately upon diagnosis, led to recovery and “virological cure” — nondetection of SARS-CoV-27 in nasal swabs — in 91.7% of patients.

According to Raoult, the drug combination “avoids worsening and clears virus persistence and contagiosness in most cases.” No cardiac toxicity was observed using a dose of 200 mg three times a day for 10 days, along with 500 mg of azithromycin on Day 1 followed by 250 mg daily for the next four days. The risk of cardiac toxicity was ameliorated by carefully screening patients and performing serial EKGs.

As reported by The Highwire (see video above), July 2, 2020, Raoult is quoted as saying failure to prescribe hydroxychloroquine to a COVID-19 patient “should be grounds for malpractice.” Meanwhile, University of Oxford investigators claim the drug is useless and shouldn’t be prescribed at all in hospitalized patients.8

An interesting website tracking hydroxychloroquine trials is c19study.com.9 It lists more than 40 studies and meta-analyses showing positive results of the drug, compared to nine that have reached a negative conclusion.

The Zelenko Regimen

Dr. Vladimir Zelenko, a primary care physician in Monroe, New York, has also reported excellent results using the drug. He told radio host Sean Hannity he’d had a near-100% success rate using hydroxychloroquine, azithromycin and zinc sulfate for five days. “I’ve seen remarkable results; it really prevents progression of disease, and patients get better,” he told Hannity.

In the video above, Del Bigtree interviews Zelenko about the criticism levied against him for promoting use of the drug. According to Zelenko, hydroxychloroquine deniers “are guilty of mass murder.”

He points out hydroxychloroquine has been used for decades and is safe even for pregnant and nursing women, so he felt very comfortable prescribing it off-label. He prescribed 200 mg of hydroxychloroquine twice a day, 500 mg of azithromycin once a day and 220 mg of zinc once a day, for five days.

The treatment was initiated within the first five days of clinical symptoms of COVID-19, based on “clinical suspicion” of SARS-CoV-2 infection (not lab confirmed testing, as test results took three days and viral load typically explodes by Day 6).

June 30, 2020, Zelenko and two co-authors published a study,10 currently in preprint, which found treating COVID-19 patients who had confirmed positive test results “as early as possible after symptom onset” with zinc, low-dose hydroxychloroquine and azithromycin “was associated with significantly less hospitalizations and five times less all-cause deaths.”

As noted by Zelenko in Bigtree’s interview, the real virus killer in this combination is actually the zinc. The hydroxychloroquine merely acts as a zinc transporter, allowing it to get into the cell. The antibiotic, meanwhile, helps prevent secondary infections.


Concerted Coordinated Effort to Inhibit Use of Effective Drug?

According to Dr. Meryl Nass, the wildly divergent views on hydroxychloroquine appear to have little to do with its safety and effectiveness against COVID-19, and more to do with a concerted and coordinated effort to prevent its use. In the video11 above, Chris Martensen Ph.D., also reviews the “profound lack of integrity” we’re currently seeing when it comes to hydroxychloroquine.

Indeed, there are several reasons for why certain individuals and companies might not want an inexpensive generic drug to work against this pandemic illness. (A 14-day supply costs just $2 to manufacture12 and can retail for as little as $20.13)

One of the most obvious reasons is because it might eliminate the need for a vaccine or other antiviral medication currently under development.14 Hundreds of millions of dollars have already been invested, and vaccine makers are hoping for a payday in the billions if not trillions of dollars. In a June 27, 2020, blog post, Nass points out:15

“It is remarkable that a series of events taking place over the past three months produced a unified message about hydroxychloroquine, and produced similar policies about the drug in the U.S., Canada, Australia, NZ and western Europe.16

The message is that generic, inexpensive hydroxychloroquine is dangerous and should not be used to treat a potentially fatal disease, COVID-19, for which there are no (other) reliable treatments.

Hydroxychloroquine has been used safely for 65 years in many millions of patients. And so the message was crafted that the drug is safe for its other uses, but dangerous when used for COVID-19. It doesn’t make sense, but it seems to have worked. Were these acts carefully orchestrated? You decide.

Might these events have been planned to keep the pandemic going? To sell expensive drugs and vaccines to a captive population? Could these acts result in prolonged economic and social hardship, eventually transferring wealth from the middle class to the very rich?”

The fight over hydroxychloroquine may also have political underpinnings. As noted by investigative reporter Sharyl Attkisson in a May 18, 2020, Full Measure report, “never before has a discussion about choices of medicine been so laced with political overtones.”

Trials Undermine Safety and Efficacy by Using Toxic Doses

Nass’ article17 lists what has occurred with regard to hydroxychloroquine so far, the intention being to keep it as a living document that will be added to as time goes on.

Nass says she wrote it in such a way that it might be read as a “to do list … to be carried out by those who pull the strings,” with the intention of suppressing use of the drug. At the time of this writing, Nass’ list18 contains 27 bullet point entries. I highly recommend reading through it, as I will only highlight a select few here.

Several items on Nass’ list detail the various ways in which safe and effective use of the drug were undermined, which allowed for a false narrative of danger to be crafted.

For example, Nass points out that three large, randomized multicenter clinical trials all used excessive dosages known to be toxic.19 These include the following. She also discusses these trials in other in-depth articles:20,21,22

The U.K. Recovery Trial23,24,25 — Funded in part by the Bill & Melinda Gates Foundation, Wellcome Trust and the U.K. government through Oxford University,26 this study randomly assigned patients to usual care or to one of five primary drug treatments: lopinavir-ritonavir; a corticosteroid (low-dose dexamethasone); hydroxychloroquine; tociizumab; or azithromycin. They also used convalescent plasma.

Patients received 2,400 mg of hydroxychloroquine during the first 24 hours — three to six times higher than the daily dosage recommended27 followed by 400 mg every 12 hours for nine more day for a cumulative dose of 9,200 mg over 10 days. The trial ended its hydroxychloroquine arm on June 4, reporting “no benefit.”

The Solidarity Trial28 — Launched by the World Health Organization and funded by 43 countries and 203,000 individuals and organizations,29 this trial also compares standard of care against four drug options, including hydroxychloroquine, among patients in 35 countries.

Strangely, the WHO does not specify the daily dosage used in the trial. However, the registration of the Canadian30 and Norwegian31 portions of the trial lists a dosage of 2,000 mg on the first day, and a cumulative dose of 8,800 mg over 10 days. This is only 400 mg less than the U.K.32 Recovery Trial’s toxic dose.

The hydroxychloroquine arm was halted May 25,33 following the publication of the Surgisphere study34 in The Lancet. June 3, after tremendous controversy had been raised over the veracity of the study, and a day before the study was retracted for using fabricated data,35,36 (and this despite having undergone peer-review), the hydroxychloroquine arm was restarted.37

June 17, 2020, the hydroxychloroquine arm was stopped again, this time “based on evidence from the Solidarity trial, U.K.’s Recovery trial and a Cochrane review of other evidence on hydroxychloroquine.”38

The REMAP-CAP Trial (Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community-Acquired Pneumonia)39 — Here, patients either received nothing, a combination of lopinavir and ritonavir, or hydroxychloroquine alone or in combination with lopinavir and ritonavir.

REMAP used the same toxic dose as the Recovery Trial but for six days instead of 10. What’s more, only critically ill hospitalized patients were included in this trial. Nass addresses other concerns as well in her June 19 blog40 about this study.

Is Lifesaving Medicine Withheld to Ensure Profits?

What possessed the study designers and investigators of these three huge clinical trials to use such exaggerated dosages? Hydroxychloroquine has been on the market for 65 years and both toxic and the effective dosages for a variety of ailments are well documented. Doctors who have reported excellent treatment results in the field stayed within the recommended hydroxychloroquine dosages.

Were they trying to purposely sabotage these trials using dosages known to be toxic? Doctors have also reported that best results are observed when the drug is administered early, while symptoms are still mild or moderate, yet in these trials the drug was not given until it was too late.

A July 1, 2020, retrospective analysis41,42,43 of 2,541 patients in the Henry Ford Hospital System in Detroit, Michigan, found use of hydroxychloroquine alone cut mortality by more than half, from 26.4% to 13.5%. (Hydroxychloroquine in combination with azithromycin had a mortality rate of 20.1%, and azithromycin alone had a mortality rate of 22.4%.)

More than 90% of the patients had received the drug or drugs within 48 hours of admission into the hospital. No adverse heart-related events were observed among those given hydroxychloroquine.

All three trials above that used toxic hydroxychloroquine doses — Recovery, Solidarity and REMAP — also failed to include zinc, which appears to be a key factor. As noted by Zelenko above, the hydroxychloroquine is really only used to drive the zinc in to the cells. Nass observes:44

“The conclusions to be drawn are frightening:

  • WHO and other national health agencies, universities and charities have conducted large clinical trials that were designed so hydroxychloroquine would fail to show benefit in the treatment of Covid-19, perhaps to advantage much more expensive competitors and vaccines in development.
  • In so doing, these agencies and charities have de facto conspired to increase the number of deaths in these trials.
  • In so doing, they have conspired to deprive billions of people from potentially benefiting from a safe and inexpensive drug, when used properly, during a major pandemic. This might contribute to prolongation of the pandemic, massive economic losses and many increased cases and deaths.”

Facets That Need To Be Discussed

Aside from that, there are two additional facets of what’s going on that are not yet being discussed:

1. What we’re seeing happen right now is that patients are being turned into guinea pigs en masse. As of June 16, 2020, the U.S. Food and Drug Administration stated the only way a patient should receive hydroxychloroquine is by enlisting in a clinical trial.45

Similarly, in the U.K., treating physicians have been asked to enroll all hospitalized COVID-19 patients into the Recovery and REMAP trials. As of July 9, 2020, Recovery had enrolled more than 12,000 subjects.46

What this means is that thousands of patients are having their treatment selected via randomization by computer rather than by their own doctors’ choice of treatment. The U.K., by the way, has one of the highest COVID-19 death rates in Europe already.47 By removing physician and patient choice of treatment, the death toll might end up being far worse than it needs to be.

Importantly, will this trend continue post-COVID? Now that doctors are being groomed to accept having their patients treated by randomization rather than with the treatment any given doctor believes to be best, will they sign up their future non-COVID patients as subjects just as easily?

2. Secondly, three recent papers48,49,50 argue that the excessive doses of hydroxychloroquine used in the Recovery Trial were not actually toxic. This creates a serious contradiction that has yet to be addressed. As noted by Nass in an email to me:

“For argument’s sake, say they are right, and even high doses are safe. Well then, why are the FDA, European Medicines Agency, pharmacy boards, governors, etc. restricting this drug that is so safe you can even overdose it and be fine?

Either the drug is so toxic at normal doses that it can’t be used for a life-threatening illness, or it is perfectly safe at extremely high doses. You can’t have it both ways.

Zinc Is a Crucial Key

In conclusion, let us circle back to where we started — with the reports of treatment success. A study51 posted on the prepublication server medRxiv, May 8, 2020, compared outcomes in hospitalized COVID-19 patients treated with either hydroxychloroquine and azithromycin alone, or Zelenko’s triplet regimen of hydroxychloroquine, azithromycin and zinc.

While the addition of zinc sulfate had no impact on the length of hospitalization, ICU duration or duration of ventilation, univariate analysis showed it was associated with other positive effects:

  • Increased hospital discharge frequency
  • Decreased the need for ventilation
  • Decreased ICU admission rates
  • Decreased the rate of transfer to hospice for non-ICU patients
  • Decreased mortality

As noted by the authors:52

“After adjusting for the time at which zinc sulfate was added to our protocol, an increased frequency of being discharged home (OR 1.53 …) reduction in mortality or transfer to hospice remained significant (OR 0.449 …). This study provides the first in vivo evidence that zinc sulfate in combination with hydroxychloroquine may play a role in therapeutic management for COVID-19.”

In short, to maximize effectiveness, you need zinc. As explained in “Is Quercetin a Safer Alternative to Hydroxychloroquine?hydroxychloroquine acts as a zinc ionophore,53,54 meaning it shuttles zinc into your cells, and zinc appears to be a “magic ingredient” required to prevent viral replication.55

If given early, zinc along with a zinc ionophore should, at least theoretically, help lower the viral load and prevent the immune system from becoming overloaded. As noted in the preprint paper, “Does Zinc Supplementation Enhance the Clinical Efficacy of Chloroquine / Hydroxychloroquine to Win Todays Battle Against COVID-19?” published April 8, 2020:56

“Besides direct antiviral effects, CQ/HCQ [chloroquine and hydroxychloroquine] specifically target extracellular zinc to intracellular lysosomes where it interferes with RNA-dependent RNA polymerase activity and coronavirus replication.

As zinc deficiency frequently occurs in elderly patients and in those with cardiovascular disease, chronic pulmonary disease, or diabetes, we hypothesize that CQ/HCQ plus zinc supplementation may be more effective in reducing COVID-19 morbidity and mortality than CQ or HCQ in monotherapy. Therefore, CQ/HCQ in combination with zinc should be considered as additional study arm for COVID-19 clinical trials.”

So far, no major clinical trial has bothered to follow this rather commonsense advice. Unfortunately, due to the corruption and politicization of science on this matter, it’s hard to offer any clear recommendations. In the end, it probably comes down to who you trust.

Quercetin — An All-Natural Safe Home Alternative

That said, if you suspect you’ve contracted COVID-19, it probably wouldn’t hurt to give a version of Zelenko’s regimen a try, at the first sign of symptoms. As explained in “Is Quercetin a Safer Alternative to Hydroxychloroquine?” quercetin is also an ionophore and has the same mechanism of action as hydroxychloroquine — it improves zinc uptake by your cells.

So, you might not need the drug. You could also swap out the antibiotic for a natural antibacterial such as olive leaf or oregano oil. You can find more information about this in “How to Improve Zinc Uptake with Quercetin to Boost Immune Health.”

Personally, I’m taking quercetin and zinc at bedtime as a prophylactic each day. The reason it’s best to take them in the evening, several hours after your last meal, and before the long fast of sleeping, is because quercetin is also a senolytic (i.e., it selectively kills senescent or old, damaged cells) that is activated by fasting. So, why not maximize the timing and use of quercetin?

+ Sources and References

Benefits of Berberine Against Chronic Disease

https://www.foundmyfitness.com/topics/berberine?

Benefits of berberine against chronic disease

iu-69

By Rhonda Patrick

Background

Berberine is an alkaloid compound present in the roots, stems, rhizomes, and bark of a variety of plants, including Californian poppy, goldenseal, cork tree, Chinese goldthread, Oregon grape, and several plants in the Berberis genus. It is also widely available as a dietary supplement. Berberine has a long history of use in the ancient and traditional medicine systems of India, China, and Persia. Animal and limited human studies demonstrate that berberine may exert pharmacological effects against certain chronic health conditions such as cardiovascular disease, gastrointestinal disorders, neurodegenerative disease, depression, and metabolic dysfunction. Preliminary research in animals also suggests that berberine may exert anti-aging properties and might be beneficial in combating aging-related diseases. However, the bulk of research involving berberine has been conducted in animals, with a paucity of trials in humans. (See link for article)

___________________

**Comment**

Berberine has been a God-send for us.  It has been shown to:

  1. lower lipids
  2. have antioxidant properties
  3. have anti-inflammatory properties
  4. reduce blood glucose levels
  5. protect the liver (in cell-culture studies)
  6. help neurodegenerative disorders
  7. have anti-depressant effects (in mice)
  8. have anti aging effects (in cells, insects, and rodents)
  9. thwarts negative effects of some pharmaceutical drugs
  10. have action against Bartonella:  https://madisonarealymesupportgroup.com/2019/05/05/good-news-for-bartonella-patients-identification-of-fda-approved-drugs-with-higher-activity-than-current-front-line-drugs/

For more:  https://madisonarealymesupportgroup.com/2019/04/05/study-shows-berberine-induces-cell-death-in-leukemia/

Interestingly, Japanese Barberry, a source of Berberine, is a hot-spot for ticks.  https://madisonarealymesupportgroup.com/2015/09/30/barberry-friend-or-foe/

https://madisonarealymesupportgroup.com/2018/06/25/juvenile-tick-attachment-on-mice-significantly-greater-in-japanese-barberry-shrubs/

https://madisonarealymesupportgroup.com/2018/01/20/manage-barberry-lower-ticks/

COVID-19 Drug Remdesivir Could Cost Up To $3,120 Per Patient, Maker Says

https://www.drugs.com/news/covid-19-remdesivir-could-cost-up-3-120-per-patient-maker-says-

COVID-19 Drug Remdesivir Could Cost Up to $3,120 Per Patient, Maker Says

MONDAY, June 29, 2020 — The maker of remdesivir, the first drug that showed promise in treating coronavirus infections, will charge U.S. hospitals $3,120 for a patient with private insurance, the drug company announced Monday.

Because of how the U.S. health care system is designed and the discounts that government health care programs like the VA and Medicaid will expect, the price for private insurance companies will be $520 per vial, Gilead Sciences explained in a letter. Most COVID-19 patients would need six vials of the drug over five days, the company said.

A lower price — $390 per vial — will be offered to other governments in developed countries around the world, Gilead added.

“As the world continues to reel from the human, social and economic impact of this pandemic, we believe that pricing remdesivir well below value is the right and responsible thing to do,” Gilead Chairman and CEO Daniel O’Day said in the company’s letter. (See link for article)

____________________

**Comment**

Our “authorities” have a financial conflict of interest in this expensive treatment:  https://principia-scientific.org/a-tale-of-2-drugs-deep-state-chose-money-power-over-lives/  Half of the COVID treatment panel has financial ties to Gilead Sciences:  https://covid19treatmentguidelines.nih.gov/panel-financial-disclosure/

Excerpt:

Approximately $70 million in U.S. taxpayer funding began Gilead’s partnership with the U.S. Army, Centers for Disease Control and Prevention (CDC) and National Institutes of Health (NIH) to develop remdesivir. Initially for treating Ebola, it failed to show benefit and was shelved. If remdesivir is used to treat COVID-19, Gilead shareholders, not the taxpayers, will profit.

Going back to 1997, Donald Rumsfeld chaired the Board of Directors at Gilead and after 2001 he held share packages valued at $5-25 Million. Gilead originally developed Tamiflu. George P Shultz, US Secretary of State also was on the board. He sold stocks at a value of more than $7 million. CA governor’s Pete Wilson’s wife also sat on the board.

‘I don’t know of any biotech company that’s’ so politically well-connected [as Gilead],‘ Andrew McDonald, of the analyst firm Think Equity Partners, told Fortune.” (Source: “Virus Mania, How the Medical Industry Continually Invents Epidemics Making Billion Dollar Profits At Our Expense”)

This article also points out an ugly conflict of interest web between Gilead, the manufacturer of Remdesivir and UNITAID which Soros, Gates, and the Clinton Health Access Initiative, are large investors – with Drs. Fauci and Birx associated with the Clinton Health Access initiative.  https://www.thegatewaypundit.com/2020/06/stunning-faucis-remdesivir-costs-9-per-dose-will-sold-3000-per-dose-china-company-linked-soros-will-also-mass-produce-drug/  And of course, Dr. Fauci has worked with Gilead for a long, long time.

Government employees should not be allowed to have financial ties to manufacturing companies and then turn around and make public health policy.

Remdesivir isn’t cheap.  It costs between $520-$390 per vial and will be sold for $3,120 per 6 vial treatment:  That’s a lot of money for a drug that hasn’t even been shown to lower viral load.

Hydroxychloroquine in the other hand costs $1 per treatment, while chloroquine costs a measly 30 cents!  https://madisonarealymesupportgroup.com/2020/05/11/podcast-evidence-supporting-hcq-azithromycin-for-covid-19/

Early results of the first clinical trial of remdesivir against placebo in coronavirus showed modest benefits, according to The New York Times. Surviving patients given remdesivir were discharged four days sooner than patients given placebo, though no criteria were given for determining improvement. Death rates were not significantly different. About 25% of patients receiving remdesivir had potentially severe side effects, including multiple organ dysfunction, septic shock, acute kidney injury and low blood pressure. Another 23% showed evidence on lab tests of liver damage.

Gilead’s own press release revealed the side effect of acute respiratory failure in 6% of patients in the remdesivir five-day treatment group, and 10.7% of patients in the 10-day treatment group, clearly ominous findings with a drug designed to treat respiratory failure caused by COVID-19.

https://madisonarealymesupportgroup.com/2020/07/02/remdesivir-for-covid-19-not-backed-by-results/

Nutritional Supplements For COVID-19 Prophylaxis and Symptom De-Escalation

https://www.linkedin.com/pulse/nutritional-supplements-covid-19-prophylaxis-symptom-chris-newton/

NUTRITIONAL SUPPLEMENTS FOR COVID-19 PROPHYLAXIS AND SYMPTOM DE-ESCALATION

Chris Newton

Research Director CIMMBER (Center for Immuno-Metabolism, Microbiome and Bio-Energetic Research)

A week ago on Friday 3rd July 2020, a call was put out on LinkedIn to biomedical scientists and physicians and all informed individuals to form Consensus-COVID, an initiative to establish a consensus list of non-prescription agents for COVID prophylaxis and symptom de-escalation. The call has so far raised around 1900 views and responses from physicians, biomedical scientists and various other professionals. What follows is a distillation of these suggestions into two lists, one for COVID prophylaxis and the other for immediate use following the onset of symptoms.

Over the past three to four months, numerous articles have been written and posted at the this site and the site of other individuals in the list below, particularly Jeannette Hospers, and Dr Ian Brighthope, concerning what might be considered a ‘trinity mix’ for COVID-19, namely vitamin C, vitamin D and a zinc salt. These three compounds will form the immutable core of both consensus lists. For more information on this combination, I would thoroughly recommend visiting the site of Dr Ian Brighthope and listening to a recent interview.

The lists below are an amalgamation of suggestions made by the following individuals in response to the call:

  • Dr John H Abeles MD, General Partner at Northlea Partners, West Palm Beach, Florida Area
  • Dr Alex (Kennerly) Vasquez DO ND DC FACN. Physician, Researcher, Presenter, Academician, Editor, Consultant 
  • Dr Ian Brighthope, Founder and Managing Director at Entoura Pty Ltd, Greater Melbourne Area
  • David Steenblock, BS, MS, DO. President, CEO, Chief Scientist, Research Physician at Personalized Regenerative Medicine, San Clemente, California
  • Dr Alan Vinitsky. Physician, Owner at Enlightened Medicine. Owner Enlightened Nutritionals & Illumivites. Washington D.C. Metro Area
  • Dr William A. Shaver. Founder at Center of Meaning in Health and Disease, Lubbock, Texas Area
  • Dr. Larry G. Martin. Cellular research related to oxidative stress. Albany, Oregon  
  • Dr Emma Derbyshire. Research, Writing, Media Liasons, Epsom, Surrey, United Kingdom 
  • Dr Jeannette Hospers. Senior Scientist/Clinical Trial Manager, Basel Area, Switzerland
  • Dr Chris Newton. Director Center for Immuno-Metabolism, Microbiome and Bio-Energetic Research, Yorkshire, UK

It must be stated that the lists below do not constitute medical advice. The clinical science and indeed clinical philosophy behind this consensus is that agents will support immune cells and other somatic cell types by acting as immuno-modulators and not immuno-suppressants. In particular, it is hoped they will prevent the accumulation of oxidants and help tailor a more appropriate immune response to SARS-CoV-2. For an excellent review on optimal nutrition and antiviral immunity see: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230749/

TABLE 1

1594895370673-2

The list above is relatively extensive and may be onerous for some individuals. A compromise might be made with supplement from companies such as Now Foods. They manufacture a combination of vitamins and minerals with addition of CoQ10 and other substances. The levels in these mixture are too low for vitamins C, and D and some minerals like magnesium, but for some of the B vitamins, they approach or exceed the lower limit in Table 1. By choosing single agent supplements, it will be possible to reach the upper limit of the range in Table 1.

In comparison to the list presented on July 3rd 2020, there are several additions and also one deletion- melatonin. This compound might be considered ‘optional’, to be taken before sleep in late evening at a dose level of 6-12mg. At least in the UK, melatonin is not easy to source and so one might consider natural products such as Feverfew. For an excellent review on natural sources of melatonin see: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409706/ .

Whilst choline is easily available as a supplement, one might also consider natural sources, such as eggs (three eggs a day will reach the dose in Table 1). Also, Brazil nuts are high in selenium and 4-5 whole nuts will provide around 200 microg.

Although it has been suggested that butyrate is appropriate to add as a supplement, for now, it is considered ‘optional’. So, 500-1000mg per day might be appropriate. This substance is produced by bacterial fermentation in the gut and it is known to inhibit inflammatory responses (see post at this site and the work of Dr Larry Martin). The decision not to add butyrate to the list in Table 1 may change following further discussion with Dr Larry Martin and Dr William Shaver.

TABLE 2

1596824042032

Immediately at the onset of symptoms increase ascorbic acid (AA) intake and vitamin D as indicated in Table 2 above. Also increase zinc and quercetin along with NAC. The latter is a thiol antioxidant and a glutathione precursor.

Whilst dropping back to the protocol in Table 1 for vitamins C (0.5-2g four times daily) and D (4000IU/day- but have blood 25OHD measured if possible and maintain D at around 80-90nmolar), after symptoms have abated, all other components in Table 1 should be maintained, if possible, at the higher dose levels for 2 weeks after onset of symptoms. Following this period, the prophylaxis ‘protocol’ of Table 1 should be resumed.

None of the above is ‘set in stone’. They are merely suggestions and a continuing dialogue concerning merits of substances (and amounts) included, and others not included, would be much appreciated.

____________________

**Comment**

Great resource.  Here’s some more:  https://madisonarealymesupportgroup.com/2020/06/15/the-functional-medicine-approach-to-covid-19-virus-specific-nutraceutical-botanical-agents/ (Many other links at the end of this article for nutritional/supplemental treatments for COVID – and just beefing up the immune system)

Food As Medicine: A Possible Preventive Measure Against COVID-19

https://pubmed.ncbi.nlm.nih.gov/32468635/

. 2020 May 28;10.1002/ptr.6770.

doi: 10.1002/ptr.6770.Online ahead of print.

Food as Medicine: A Possible Preventive Measure Against Coronavirus Disease (COVID-19)

Abstract

The recent and ongoing outbreak of coronavirus disease (COVID-19) is a huge global challenge. The outbreak, which first occurred in Wuhan City, Hubei Province, China and then rapidly spread to other provinces and to more than 200 countries abroad, has been declared a global pandemic by the World Health Organization (WHO). Those with compromised immune systems and/or existing respiratory, metabolic or cardiac problems are more susceptible to the infection and are at higher risk of serious illness or even death.

The present review was designed to report important functional food plants with immunomodulatory and anti-viral properties. Data on medicinal food plants was retrieved and downloaded from English-language journals using online search engines. The functional food plants herein documented might not only enhance the immune system and cure respiratory tract infections but can also greatly impact the overall health of the general public. As many people in the world are now confined to their homes, inclusion of these easily accessible plants in the daily diet may help to strengthen the immune system and guard against infection by SARS-CoV-2. This might reduce the risk of COVID-19 and initiate a rapid recovery in cases of SARS-CoV-2 infection.

___________________

**Comment**

It is a rare day indeed when research actually mentions the importance of food in health.  Since we know it’s the immunocompromised who are hit hardest, that should be the focus – NOT MASKS, which in and of themselves are actually immunosuppressive and prohibit you from properly breathing, attract germs, and cause a lot of irritation.

For more:  https://madisonarealymesupportgroup.com/2020/06/15/the-functional-medicine-approach-to-covid-19-virus-specific-nutraceutical-botanical-agents/

For Dr. Waters’ presentation to the support group which goes far deeper into the topic:

It’s also quite telling that “authorities”, with a complicit media, won’t talk about effective treatments that ARE currently working – only expensive drugs that don’t work as well, and of course the supposed “magic bullet” vaccine the world is holding its breath for that’s scary as hell:  https://madisonarealymesupportgroup.com/2020/06/02/successful-covid-19-critical-care-stonewalled-by-cdc/

Oh, then there’s that sticky little issue that the NIH is in bed with Moderna, a manufacturer of the COVID vaccine, and our “authorities” stand to gain large profit from it:  https://madisonarealymesupportgroup.com/2020/07/08/new-docs-nih-owns-half-of-moderna-vaccine/